The demise of portable monitoring to diagnose OSA? not so fast!

Sleep

Volumn 34, Issue 6, 2011, Pages 691-692

  Ayas, Najib T ^a   Pack, Allan ^b   Marra, Carlo ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART INFARCTION; HOME MONITORING; HUMAN; NOTE; OUTCOME ASSESSMENT; PATIENT MONITORING; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP APNEA SYNDROME; STROKE; TRAFFIC ACCIDENT;

CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 79957954731     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/SLEEP.1026     Document Type: Note

References (7)

1. http://www.oecd.org accessed March 22, 2011.
2. rd ed). New York: Oxford University Press, 2005.
3. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003;163:1637-41.
4. Pietzsch JB, Garner A, Cipriano LE, Linehan JH. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea. Sleep 2011;34:695-709.
5. Ayas NT, FitzGerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-84.
6. Mar J, Rueda JR, Durán-Cantolla J, Schechter C, Chilcott J. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J 2003;21:515-22. (Pubitemid 36336214)
7. Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 2009;51:285-93.